News
June 22, 2021•From Ram Rao, Insider Strategies, News
Exercise protects the body and brain, and releases osteocalcin, a hormone secreted from our skeletal system that plays a role in memory, mood and brain resilience. Read More »
June 22, 2021•Behavior Change, Insider Strategies, News
It takes more than the slogan ” Just do it” to embark on a successful journey to brain health with PreCODE and ReCODE. Instead, it takes an authentic change in mindset and a personalized toolkit with of a variety of skills to be successful and adhere to the protocol. Read More »
June 21, 2021•KetoFLEX 12/3 Kitchen, News, Nutrition, Recipes
KetoFLEX 12/3 Kitchen: Simple and Refreshing Japanese Cuisine
KetoFLEX 12/3 Kitchen celebrates summer with fresh Japanese-themed recipes Chirashi Bowl, Ginger Dressing, and Matcha Madness Ice Cream a great source of neuroprotective EGCG. Read More »
June 21, 2021•From Julie Gregory, Insider Strategies, News
Julie Gregory offers tips and planning strategies to stay on the protocol while traveling. Read More »
June 18, 2021•From Dr. Bredesen, News
Far Reaching Implications of the Aducanumab Debacle
Dr. Bredesen discusses the far reaching implications of the FDA’s controversial approval of the drug Aduhelm, rejected by its own independent advisory panel. Read More »
June 11, 2021•Facebook Live Videos, News, Past Events
Facebook Live: What Does Aducanumab Mean for Alzheimer’s?
Dr. Dale Bredesen and Julie Gregory discussed the FDA’s approval Biogen’s drug Aduhelm and the ramifications for those seeking treatment for Alzheimer’s. Read More »
June 9, 2021•News
Aducanumab vs. the ReCODE Protocol
The recently FDA approved Aduhelm did not improve cognition but mildly slowed down disease progression with dangerous side effects compared to the ReCODE Protocol, which in a recent trial demonstrated that 84% of the participants improved cognition with health optimization as the only side effect. Read More »
June 9, 2021•Interviews, News
FDA Approves New Alzheimer’s Drug Despite Little Evidence it Works
Dr. Bredesen speaks with CBN News’ reporter, Lorie Johnson, about the recent FDA approval of the Alzheimer’s drug Aduhelm. Read More »